Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-14-004134

Director bought 370,000 shares at $2.65 ($980,500)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS LP · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2014-07-22 Purchase : show line 1 in the form +100,000 $2.65 $265,000 13,522,262 D
2014-07-22 Purchase : show line 2 in the form +0 13,522,262 I
2014-07-22 Purchase : show line 3 in the form +270,000 $2.65 $715,500 13,792,262 D
2014-07-22 Purchase : show line 4 in the form +0 13,792,262 I
Open-market purchases · 370,000 sh · avg $2.65 · $980,500
Loading xslF345X03/p6058416.xml…